248 related articles for article (PubMed ID: 18202104)
1. Recessive hereditary methaemoglobinaemia, type II: delineation of the clinical spectrum.
Ewenczyk C; Leroux A; Roubergue A; Laugel V; Afenjar A; Saudubray JM; Beauvais P; Billette de Villemeur T; Vidailhet M; Roze E
Brain; 2008 Mar; 131(Pt 3):760-1. PubMed ID: 18202104
[TBL] [Abstract][Full Text] [Related]
2. Recessive hereditary methemoglobinemia: two novel mutations in the NADH-cytochrome b5 reductase gene.
Fermo E; Bianchi P; Vercellati C; Marcello AP; Garatti M; Marangoni O; Barcellini W; Zanella A
Blood Cells Mol Dis; 2008; 41(1):50-5. PubMed ID: 18343696
[TBL] [Abstract][Full Text] [Related]
3. Recessive congenital methaemoglobinaemia: cytochrome b(5) reductase deficiency.
Percy MJ; Lappin TR
Br J Haematol; 2008 May; 141(3):298-308. PubMed ID: 18318771
[TBL] [Abstract][Full Text] [Related]
4. Congenital methemoglobinemia due to NADH-methemoglobin reductase deficiency in three Indian families.
Kedar PS; Colah RB; Ghosh K; Mohanty D
Haematologia (Budap); 2002; 32(4):543-9. PubMed ID: 12803131
[TBL] [Abstract][Full Text] [Related]
5. Identification and characterization of the novel FAD-binding lobe G75S mutation in cytochrome b(5) reductase: an aid to determine recessive congenital methemoglobinemia status in an infant.
Percy MJ; Crowley LJ; Roper D; Vulliamy TJ; Layton DM; Barber MJ
Blood Cells Mol Dis; 2006; 36(1):81-90. PubMed ID: 16310381
[TBL] [Abstract][Full Text] [Related]
6. Recessive congenital methaemoglobinaemia: functional characterization of the novel D239G mutation in the NADH-binding lobe of cytochrome b5 reductase.
Percy MJ; Crowley LJ; Davis CA; McMullin MF; Savage G; Hughes J; McMahon C; Quinn RJ; Smith O; Barber MJ; Lappin TR
Br J Haematol; 2005 Jun; 129(6):847-53. PubMed ID: 15953014
[TBL] [Abstract][Full Text] [Related]
7. A novel L218P mutation in NADH-cytochrome b5 reductase associated with type I recessive congenital methemoglobinemia.
Arikoglu T; Yarali N; Kara A; Bay A; Bozkaya IO; Tunc B; Percy MJ
Pediatr Hematol Oncol; 2009; 26(5):381-5. PubMed ID: 19579085
[TBL] [Abstract][Full Text] [Related]
8. A rare cause of mental motor retardation: recessive congenital methemoglobinemia type II.
Yüksel D; Senbil N; Yilmaz D; Yarali N; Gürer YK
Turk J Pediatr; 2009; 51(2):187-9. PubMed ID: 19480335
[TBL] [Abstract][Full Text] [Related]
9. NADH-cytochrome b5 reductase in a Turkish family with recessive congenital methaemoglobinaemia type I.
Percy MJ; Aslan D
J Clin Pathol; 2008 Oct; 61(10):1122-3. PubMed ID: 18820099
[TBL] [Abstract][Full Text] [Related]
10. [Clinical and biological forms of cytochrome b5 reductase deficiency].
Kaplan JC; Leroux A; Beauvais P
C R Seances Soc Biol Fil; 1979; 173(2):368-79. PubMed ID: 159760
[TBL] [Abstract][Full Text] [Related]
11. Severe neurological impairment in hereditary methaemoglobinaemia type 2.
Toelle SP; Boltshauser E; Mössner E; Zurbriggen K; Eber S
Eur J Pediatr; 2004 Apr; 163(4-5):207-9. PubMed ID: 14986124
[TBL] [Abstract][Full Text] [Related]
12. A Thai boy with hereditary enzymopenic methemoglobinemia type II.
Shotelersuk V; Tosukhowong P; Chotivitayatarakorn P; Pongpunlert W
J Med Assoc Thai; 2000 Nov; 83(11):1380-6. PubMed ID: 11215870
[TBL] [Abstract][Full Text] [Related]
13. Clinical spectrum and molecular basis of recessive congenital methemoglobinemia in India.
Warang PP; Kedar PS; Shanmukaiah C; Ghosh K; Colah RB
Clin Genet; 2015; 87(1):62-7. PubMed ID: 24266649
[TBL] [Abstract][Full Text] [Related]
14. [Prenatal diagnosis of generalized cytochrome b5 reductase deficiency (congenital methemoglobinemia with mental retardation, type II) (author's transl)].
Kaplan JC; Junien C; Leroux A; Bamberger J; Bakouri S; Boué J; Boué A
Ann Med Interne (Paris); 1981; 132(2):93-6. PubMed ID: 7235451
[TBL] [Abstract][Full Text] [Related]
15. [Hereditary methemoglobinemias].
Beauvais P
Arch Pediatr; 2000 May; 7(5):513-8. PubMed ID: 10855391
[TBL] [Abstract][Full Text] [Related]
16. Prenatal diagnosis of recessive congenital methaemoglobinaemia type II: novel mutation in the NADH-cytochrome b5 reductase gene leading to stop codon read-through.
Leroux A; Leturcq F; Deburgrave N; Szajnert MF
Eur J Haematol; 2005 May; 74(5):389-95. PubMed ID: 15813912
[TBL] [Abstract][Full Text] [Related]
17. [Genetics and biochemistry of NADH-cytochrome b5 reductase].
Shirabe K
Nihon Rinsho; 2004 Dec; 62 Suppl 12():765-7. PubMed ID: 15658445
[No Abstract] [Full Text] [Related]
18. Neurometabolic disorder with microcephaly, dystonia, and central cyanosis masquerading as cerebral palsy.
Devadathan K; Sreedharan M; Sarasam S; Colah RB; Kunju PA
J Child Neurol; 2014 Nov; 29(11):NP139-42. PubMed ID: 24413360
[TBL] [Abstract][Full Text] [Related]
19. Cytochrome b5 reductase: the roles of the recessive congenital methemoglobinemia mutants P144L, L148P, and R159*.
Davis CA; Crowley LJ; Barber MJ
Arch Biochem Biophys; 2004 Nov; 431(2):233-44. PubMed ID: 15488472
[TBL] [Abstract][Full Text] [Related]
20. A novel G143D mutation in the NADH-cytochrome b5 reductase gene in an Indian patient with type I recessive hereditary methemoglobinemia.
Kedar PS; Warang P; Nadkarni AH; Colah RB; Ghosh K
Blood Cells Mol Dis; 2008; 40(3):323-7. PubMed ID: 17964195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
